UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS by Manfredi, Andreina Teresa et al.
FRI0451 (2015) 
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED 
CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS  
A. manfredi, M. Sebastiani, S. Cerri, G. Della Casa, D. Giuggioli, C. Vacchi, M. Colaci, A. 
Spinella, F. Luppi, C. Ferri 
University of Modena and Reggio Emilia, Modena, Italy 
Background: Interstitial lung disease (ILD) includes a group of disorders of the pulmonary 
parenchyma including ILD secondary to environmental exposure, to sarcoidosis and connective 
tissue diseases, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonitis. Unclassifiable-
ILD (U-ILD) is defined when ILD cannot be included in one of these subtypes, because of 
inadequate findings or impossibility to complete diagnostic iter. Undifferentiated connective tissue 
disease (UCTD) is a systemic autoimmune diseases characterized by clinical and serological 
features typical of other CTD, but not fulfilling any of the existing classification criteria. It has been 
recently suggested that UCTD should be responsible for ILD, although the available classification 
criteria do not consider lung manifestations. Differential diagnosis between U-ILD or ILD 
secondary to UCTD (UCTD-ILD) can be difficult, but fundamental for therapeutic implications. 
Objectives: To evaluate the clinical and serological features of patients with ILD secondary to 
UCTD compared to unclassifiable ILD, to improve differential diagnosis and identify patients 
candidate to immuno-suppressive therapy. Secondary outcome was to construct a clinical algorithm, 
using a priori variables, helpful to predict ILD-UCTD in clinical practice. 
Methods: From September 2011 to November 2014, 50 patients referred to our Center were 
diagnosed for UCTD (26/50) or U-ILD (24/50), after a multidisciplinary discussion according to 
standard available criteria. 
Results: Main features and comparison between UCTD-ILD and U-ILD are reported in the table. 
An inconsistent with usual interstitial pneumonia (UIP) pattern at high resolution computerized 
tomography (HRCT) was more frequently detected in UCTD-ILD compared to U-ILD. A predictive 
model based on Raynaud's phenomenon, ocular dryness, and antinuclear antibodies showed a 
predictive value of 85.7% (UCTD-ILD were correctly classified in 90.5% and U-ILD in 78.6%). 
Clinical and demographic features of patients with interstitial lung disease 
 UCTD U-ILD p 
Number of patients 26 24  
Sex 19F/7M 14F/10M ns 
Age at diagnosis 61.7±12.7 67.1±9.1 ns 
Raynaud's phenomenon 68.0% 29.4% 0.027 
Oral dryness 60.0% 35.3% ns 
Ocular dryness 60.0% 13.3% 0.007 
Schirmer test 41.6% 4.2% 0.006 
Arthritis 19.2% 0 0.05 
Skin manifestations 30.4% 0 0.029 
Thrombocytopenia 16.7% 18.2% ns 
Anemia 33.3% 18.2% ns 
Antinuclear antibodies 87% 52.4% 0.02 
 UCTD U-ILD p 
ENA 38.1% 10% ns 
Rheumatoid factor 13.6% 9.1% ns 
UIP pattern to HRCT 41.2% 58.8% ns 
Inconsitent with UIP pattern to HRCT 66.7% 33.3% ns 
Conclusions: Lung involvement is a possible presenting symptom of UCTD; therefore, differential 
diagnosis with U-ILD is crucial due to the relevant therapeutic implications; a multidisciplinary 
approach, including rheumatologist, pulmonologist, radiologist, and pathologist, is mandatory. 
Some clinical-serological features potentially helpful in differential diagnosis should be carefully 
evaluated 
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